Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma

Journal of Clinical Oncology

Volumn 34, Issue 23, 2016, Pages 2761-2768

  Rimner, Andreas ^a   Zauderer, Marjorie G ^a   Gomez, Daniel R ^b   Adusumilli, Prasad S ^a   Parhar, Preeti K ^a   Wu, Abraham J ^a   Woo, Kaitlin M ^a   Shen, Ronglai ^a   Ginsberg, Michelle S ^a   Yorke, Ellen D ^a   Rice, David C ^b   Tsao, Anne S ^b   Rosenzweig, Kenneth E ^a   Rusch, Valerie W ^a   Krug, Lee M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PEMETREXED; PREDNISONE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DERMATITIS; DISEASE COURSE; DYSPNEA; ESOPHAGITIS; FEMALE; HEMITHORACIC INTENSITY MODULATED PLEURAL RADIATION THERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG RESECTION; LUNG SURGERY; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; OVERALL SURVIVAL; PERICARDITIS; PHASE 2 CLINICAL TRIAL; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION PNEUMONIA; THORACOTOMY; VOMITING; ADVERSE EFFECTS; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; LUNG; MESOTHELIOMA; MIDDLE AGED; MULTICENTER STUDY; PLEURAL NEOPLASMS; PROCEDURES; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONITIS; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG; MALE; MESOTHELIOMA; MIDDLE AGED; ORGAN SPARING TREATMENTS; PEMETREXED; PLEURAL NEOPLASMS; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE;

EID: 84981272183     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.67.2675     Document Type: Article

References (21)

1. Rusch VW, Rosenzweig K, Venkatraman E, et al: A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122:788-795, 2001
2. Rice DC, Stevens CW, Correa AM, et al: Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84:1685-1692, 2007; discussion 1692-1693
3. Forster KM, Smythe WR, Starkschall G, et al: Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant me-sothelioma: Clinical implementation. Int J Radiat Oncol Biol Phys 55:606-616, 2003
4. Gupta V, Krug LM, Laser B, et al: Patterns of local and nodal failure in malignant pleural meso-thelioma after extrapleural pneumonectomy and photon-electron radiotherapy. J Thorac Oncol 4:746-750, 2009
5. Taioli E, Wolf AS, Flores RM: Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg 99:472-480, 2015
6. Sharkey AJ, Tenconi S, Nakas A, et al: The effects of an intentional transition from extrapleural pneumo-nectomy to extended pleurectomy/decortication. Eur J Cardiothorac Surg 49:1632-1641, 2015
7. Gupta V, Mychalczak B, Krug L, et al: Hemi-thoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 63:1045-1052, 2005
8. Rosenzweig KE, Zauderer MG, Laser B, et al: Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 83:1278-1283, 2012
9. Rimner A, Rosenzweig KE: Novel radiation therapy approaches in malignant pleural meso-thelioma. Ann Cardiothorac Surg 1:457-461, 2012
10. Byrne MJ, Nowak AK: Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15:257-260, 2004
11. Rice D, Rusch V, Pass H, et al: Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: A consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol 6:1304-1312, 2011
12. Rimner A, Spratt DE, Zauderer MG, et al: Failure patterns after hemithoracic pleural intensity-modulated radiation therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 90:394-401, 2014
13. Krug LM, Pass HI, Rusch VW, et al: Multi-center phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 27:3007-3013, 2009
14. Allen AM, Czerminska M, Jänne PA, et al: Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65:640-645, 2006
15. Rice DC, Smythe WR, Liao Z, et al: Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 69:350-357, 2007
16. Gomez DR, Hong DS, Allen PK, et al: Patterns of failure, toxicity, and survival after extrapleural pneu-monectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesotheli-oma. J Thorac Oncol 8:238-245, 2013
17. Stahel RA, Riesterer O, Xyrafas A, et al: Neoadjuvant chemotherapy and extrapleural pneu-monectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): A randomised, international, multicentre phase 2 trial. Lancet Oncol 16:1651-1658, 2015
18. Rimner A, Simone CB, II, Zauderer MG, et al: Hemithoracic radiotherapy for mesothelioma: Lack of benefit or lack of statistical power? Lancet Oncol 17:e43-e44, 2016
19. Flores RM, Pass HI, Seshan VE, et al: Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients. J Thorac Cardiovasc Surg 135:620-626, 626.e1-626. e3, 2008
20. Treasure T, Lang-Lazdunski L, Waller D, et al: Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12:763-772, 2011
21. Patel PR, Yoo S, Broadwater G, et al: Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 83:362-368, 2012